India has emerged as a global powerhouse in the pharmaceutical sector, renowned for its affordable medications and robust manufacturing capabilities. However, beneath the surface of this success lies a complex landscape marked by concerns regarding monopolies and market dominance. A handful of large pharmaceutical companies have established signifi